icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Combination of ASK1 and ACC Inhibitors Increases Efficacy in Rodent Models of NASH
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
 
Jamie Bates, David Hollenback, Anna Zagorska, Grant R. Budas, John T. Liles, Henry Liu, Kathy Liu, Saritha Kusam,
Robert Brockett, David Newstrom, Igor Mikaelian, David G. Breckenridge Gilead Sciences, Inc., Foster City, CA

1113171

1113172

1113173

1113174

1113175

1113176

1113177

1113178

References
 
1. Ichijo H, et al. Science 1997;275:90-4; 2. Schuster S, Feldstein AE. Nat Rev Gastroenterol Hepatol 2017;14:329-30; 3. Yamamoto E, et al.
Hypertension 2008;52:573-80; 4. Diehl AM, et al. J Hepatol 2017;66:S51-2; 5. Loomba R, et al. J Hepatol 2017;66:S671; 6. Abu-Elheiga L, et al.
Proc Natl Acad Sci USA 2005;102:12011-6; 7. Mao J, et al. Proc Natl Acad Sci USA 2006;103:8552-7; 8. Harriman G, et al. Proc Natl Acad Sci USA
2016;113:E1796-805; 9. Lawitz EJ, et al. EASL 2017, abstr LBO-002; 10. Loomba R, et al. AASLD 2017, abstr LB-9; 11. Charlton M, et al. Am J
Physiol Gastrointest Liver Physiol 2011;301:G825-34.